Valeritas
Bridgewater, US · 7 known investors
Founders & leadership
WD
William DukeNamed on SEC filing
DP
Daniel PelakNamed on SEC filing
ST
Sean TraynorNamed on SEC filing
SL
Steve LaPorteNamed on SEC filing
IH
Ittai HarelNamed on SEC filing
PQ
Paul QueallyNamed on SEC filing
JB
John BarrNamed on SEC filing
JR
John RyanNamed on SEC filing
KP
Kristine PetersonNamed on SEC filing
TF
Todd FoleyNamed on SEC filing
Investors · 7
Reported raises · per SEC filings
Form D private placements$22M disclosed across 1 round · 2014
▶$22MraisedJul 2014 · 26 investors · Other TechnologyRule 506(b)
▶$22MraisedJul 2014 · 26 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- William DukeExecutive Officer
- Daniel PelakDirector
- Sean TraynorDirector
- Steve LaPorteDirector
- Ittai HarelDirector
- Paul QueallyDirector
- John BarrDirector
- John RyanDirector
- Kristine PetersonExecutive Officer, Director
- Todd FoleyDirector
- Offering amount
- $45M
- Amount sold
- $22M
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Valeritas's investors?
- Valeritas's investors include Agate Medical Investments LP, Kaiser Permanente Ventures, Abingworth, HLM Venture Partners, MPM BioImpact, Pitango, Welsh, Carson, Anderson & Stowe.
- How much funding has Valeritas raised?
- Valeritas has disclosed $22M raised across 1 round.
- Where is Valeritas headquartered?
- Valeritas is headquartered in Bridgewater, US.